Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

What explains the diffusion of treatments for mental illness?

Drake R, Skinner J, Goldman HH.

Am J Psychiatry. 2008 Nov;165(11):1385-92. doi: 10.1176/appi.ajp.2008.08030334. No abstract available.

2.
3.
4.

The cost of schizophrenia.

Wasylenki DA.

Can J Psychiatry. 1994 Nov;39(9 Suppl 2):S65-9. Review.

PMID:
7874667
5.

Closing gaps in mental health care for persons with serious mental illness.

Mechanic D.

Health Serv Res. 2001 Dec;36(6 Pt 1):1009-17. Review. No abstract available.

6.

Treatment of schizophrenia: let's talk dollars and sense.

Buckley PF.

Am J Manag Care. 1998 Mar;4(3):369-83. Review. Erratum in: Am J Manag Care 1998 Apr;4(4):611.

7.

Medicaid policies to contain psychiatric drug costs.

Koyanagi C, Forquer S, Alfano E.

Health Aff (Millwood). 2005 Mar-Apr;24(2):536-44. Review.

8.
9.
10.

Psychiatric care and health insurance reform.

Sharfstein SS, Stoline AM, Goldman HH.

Am J Psychiatry. 1993 Jan;150(1):7-18. Review.

PMID:
8417583
11.

Relationship between costs and symptoms in schizophrenia patients treated with antipsychotic medication: a review.

Sevy S, Visweswaraiah H, Mentschel C, Leucht S, Schooler NR.

J Clin Psychiatry. 2004 Jun;65(6):756-65. Review.

PMID:
15291652
12.

[Expensive but nevertheless cost effect? Pharmacoeconomics of atypical neuroleptics].

Laux G, G√ľnther W.

Pharm Unserer Zeit. 2002;31(6):572-6. Review. German. No abstract available.

PMID:
12481515
13.

Treatment of common mental disorders in primary care in low- and middle-income countries.

Siddiqi K, Siddiqi N.

Trans R Soc Trop Med Hyg. 2007 Oct;101(10):957-8. Epub 2007 May 30. Review.

PMID:
17540425
14.

Research policy implications of cost-of-illness studies for mental disorders.

Rupp A, Gause EM, Regier DA.

Br J Psychiatry Suppl. 1998;(36):19-25. Review. No abstract available.

PMID:
9829007

Supplemental Content

Support Center